Bicyclic CX3CR1 receptor agonists
US11958839B2 · kind B2 · utility
1Cited by
2References
34Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 22, 2021 |
| Grant date | Apr 16, 2024 |
| Priority date | — |
| Expiry date | Sep 22, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/32
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed herein are novel cycloalka[b]heteroaryl compounds having CX3CR1/fractalkine receptor (CX3CR1) agonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment or prophylaxis of diseases associated with CX3CR1 receptor activity in animals, in particular humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.